
BCAB
USDBioAtla Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$0.650
Haut
$0.678
Bas
$0.613
Volume
0.11M
Fondamentaux de l'Entreprise
Capitalisation Boursière
39.5M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
1.01M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its
Actions Connexes
GNK
Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands)
THCPU
Thunder Bridge Capital Partners IV Inc. Unit
TPC
Tutor Perini Corporation
NMI
Nuveen Municipal Income Fund Inc.
FOSLL
Fossil Group Inc. 7% Senior Notes due 2026
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.